| Organization Name | Columbia Tech Ventures |
|---|---|
| Institutional ID Number | 9966 |
| Technology Tags or Keywords | |
| Summary | Isolated ABCA1 protein having a mutation within its PEST domain, related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture are described. |
| Technology Benefit | -- |
| Technology Applications | -- |
| Technology page URL | http://techventures.columbia.edu |
| Detailed Technology Description | -- |
| TTO homepage URL | -- |
| URL to link to documents, images, videos, etc. | -- |
| Additional Information | Track CodeP9966 IR #1293 SummaryLead Inventors: Nan Wang Isolated ABCA1 protein having a mutation within its PEST domain, related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture are described. A method for increasing the formation of HDL in a subject comprising administering to the subject an agent that inhibits the PEST-mediated proteolysis of ABCA1 protein in the subject's cells is described. An article of manufacture comprises a packaging and a pharmaceutical agent. The methods can be used for determining whether a protease inhibitor increases the rate of cholesterol efflux from a cell and for increasing ABCA1-mediated cholesterol efflux from a cell and for increasing HDL formation in a subject, thereby treating atherosclerosis in a subject. Web LinksPatent number: US20040096851 InquiryPeter Golikov Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu |